Physician profile
Gregory Rowe
NPI 1477844959
$6,186.63
in general payments reported to CMS, 2019-2025
18 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $775 · 2021: $2,622 · 2022: $40.35 · 2023: $532 · 2024: $1,027 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,577.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,642.17 | 2020-2025 | Citrefix, Ortholoc 2 Lapifuse, Ortholoc 3di |
| Mimedx Group, INC. | $1,493.12 | 2024-2025 | |
| Wright Medical Technology, INC. | $467.41 | 2019-2020 | |
| Depuy Synthes Sales INC. | $361.86 | 2021-2025 | Motoband, Vivigen Mis Delivery System, Hammerlock2 |
| Orthofix Medical, INC. | $317.95 | 2019-2025 | Physio-Stim |
| Sanara Medtech INC. | $287.96 | 2023-2024 | Celleraterx |
| Anika Therapeutics, INC. | $261.86 | 2021-2023 | Integrity, Tactoset |
| Convatec INC. | $88.20 | 2023 | |
| Organogenesis INC. | $61.28 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $48.23 | 2019 | |
| Integra Lifesciences Corporation | $34.54 | 2021 | |
| Smith+Nephew, INC. | $33.07 | 2021 | |
| Allergan, INC. | $18.35 | 2020 | |
| Fidia Pharma USA INC. | $16.57 | 2019 | |
| Kci USA, INC. | $15.07 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $13.70 | 2019 | |
| Medline Industries Lp | $13.09 | 2019 | |
| Assertio Therapeutics, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.